Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 

Translational Research

Cancer Research UK receives largest ever donation

Cancer Research UK has been given a gift of Ј10 million from one of its supporters. This is the largest one-off donation the charity has ever received, and comes alongside...

UKCMRI to be renamed The Francis Crick Institute

The UK Centre for Medical Research and Innovation, is to be re-named The Francis Crick Institute in honour of one of the nation's greatest scientists.

Cancer Research UK leads global lung cancer drug trial

Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The...

CRT, University of Manchester and AstraZeneca work together to seek new cancer drugs

CANCER RESEARCH TECHNOLOGY, the commercial arm of Cancer Research UK, the University of Manchester and AstraZeneca today announced two agreements to seek new cancer drugs...

'Treatment alliance' needed to save more children's lives from cancer

Experts are calling for an urgent change to approaches for treating and researching childhood cancers to continue to save more children.

Experimental drug shrinks tumours in women with hereditary breast and ovarian cancers

An experimental drug called olaparib has been shown to shrink tumours in women whose advanced cancers were caused by faults in their BRCA genes.

Cancer Research Technology, The ICR and ZoBio BV sign deal to develop cancer drugs

Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs...

Experimental drug may work in many cancers

Scientists have shown that a new class of cancer drugs called PARP inhibitors, currently being tested in clinical trials to treat breast and ovarian cancer could have...

Trial drug 'effective' against cancers with faulty BRAF gene

An experimental drug designed to treat cancers with a particular genetic fault has shown promising results in a small clinical trial.

Cancer Research UK and CRT sign deal with Centella Therapeutics, inc to launch clinical development of radiotherapy-enhancing drug

Cancer Research UK and Cancer Research Technology, the charity's development and commercialisation arm, have partnered with Centella Therapeutics, Inc. of Palo Alto,...

Pages